Childhood Cancer Data Initiative Annual Symposium (Abstract Registration): Submission #45
Submission information
Submission Number: 45
Submission ID: 149218
Submission UUID: 4ee8fa76-2276-4b27-929f-454707b5521e
Submission URI: /nci/ccdisymposium/abstract
Created: Tue, 08/19/2025 - 12:15
Completed: Tue, 08/19/2025 - 14:30
Changed: Tue, 08/19/2025 - 14:30
Remote IP address: 10.208.28.152
Submitted by: Anonymous
Language: English
Is draft: No
Abstract Submission for Poster Presentation
-------------------------------------------
Abstract Title:: Enrollment in Children’s Oncology Group’s Clinical Trials: Population-Based Linkage with the National Childhood Cancer Registry
Abstract::
Background: Improvements in outcomes among children and adolescents diagnosed with cancer are attributable to many factors, including clinical trials such as those administered through the Children’s Oncology Group (COG), as well as population-based resources like the National Childhood Cancer Registry (NCCR). The objective of this study was to link COG trial data with the NCCR to evaluate overall enrollment patterns.
Methods: Data were received from the NCCR and COG, which were linked using an array of variables and then compared to evaluate enrollment patterns in COG studies from 2007-2018. Multivariable logistic regression was used to identify characteristics associated with not being enrolled in a COG study.
Results: Among 134,696 NCCR cancer patients, 51,062 matched with COG study enrollees. There were several differences in demographic and clinical characteristics between those enrolled and not enrolled in COG studies. Enrollment was higher among children aged 0-4 years compared to adolescents aged 15-19 years (53.7% vs 20.1%). Differences by race and ethnicity were also observed; for example, those who identified as non-Hispanic White were more likely to be enrolled than those who identified as non-Hispanic Asian/Pacific Islander (38.8% vs 32.9%). In a multivariable logistic regression model, several characteristics were significantly associated with not being enrolled in a COG study, including age at diagnosis, year of diagnosis, race and ethnicity, and cancer type.
Conclusion: Our results suggest that several groups are underrepresented in COG clinical trials. This information can help guide the prioritization of population groups for engagement in future studies.
Abstract:: {Empty}
Authors::
1. First Name: Philip
Middle Initial: J
Last Name: Lupo
Degree(s): Ph.D.
Organization: Emory University
2. First Name: David
Middle Initial: A
Last Name: Siegel
Degree(s): M.D., MPH
Organization: Centers for Disease Control and Prevention
3. First Name: Nicola
Middle Initial: C
Last Name: Schussler
Degree(s): BS
Organization: Information Management Services, Inc
4. First Name: Todd
Middle Initial: A
Last Name: Alonzo
Degree(s): Ph.D.
Organization: University of Southern California
5. First Name: Suzanne
Last Name: Adams
Degree(s): ODS-C, BS
Organization: Information Management Services, Inc
6. First Name: David
Last Name: Angelaszek
Degree(s): MS
Organization: Information Management Services, Inc
7. First Name: Shanthala
Last Name: Basavappa
Degree(s): MS
Organization: Essex, an Emmes Company
8. First Name: Tiffany
Middle Initial: M
Last Name: Chambers
Degree(s): MPH
Organization: Baylor College of Medicine
9. First Name: Linda
Last Name: Colye
Degree(s): BS
Organization: Information Management Services, Inc
10. First Name: Eric
Last Name: Durbin
Degree(s): Dr.PH., MS
Organization: University of Kentucky
11. First Name: Johanna
Middle Initial: L
Last Name: Goderre
Degree(s): MPH
Organization: National Cancer Institute
12. First Name: Tiffany
Last Name: Hayes
Degree(s): MPH
Organization: Essex, an Emmes Company
13. First Name: Will
Last Name: Howe
Degree(s): BS
Organization: Information Management Services, Inc
14. First Name: Elizabeth
Last Name: Hsu
Degree(s): Ph.D.
Organization: National Cancer Institute
15. First Name: Richard
Last Name: Lee
Degree(s): BS
Organization: Information Management Services, Inc
16. First Name: Denise
Middle Initial: R
Last Name: Lewis
Degree(s): Ph.D., MPH
Organization: National Cancer Institute
17. First Name: Angela
Middle Initial: B
Last Name: Mariotto
Degree(s): Ph.D.
Organization: National Cancer Institute
18. First Name: Brad
Middle Initial: H
Last Name: Pollock
Degree(s): Ph.D., MPH
Organization: University of California Davis
19. First Name: Anca
Last Name: Preda
Degree(s): M.D., MPH
Organization: National Cancer Institute
20. First Name: Michael
Middle Initial: E
Last Name: Roth
Degree(s): M.D.
Organization: The University of Texas MD Anderson Cancer Center
21. First Name: Jennifer
Last Name: Stevens
Degree(s): BS
Organization: Information Management Services, Inc
22. First Name: Tina
Last Name: Terranova
Degree(s): MSc
Organization: ICF
23. First Name: Sarah
Middle Initial: L
Last Name: Vargas
Degree(s): Ph.D.
Organization: Children's Oncology Group
24. First Name: Douglas
Middle Initial: S
Last Name: Hawkins
Degree(s): M.D.
Organization: University of Washington
25. First Name: Lynne
Last Name: Penberthy
Degree(s): M.D., MPH
Organization: National Cancer Institute
Presenting Author:: David Siegel
Institution:: Centers for Disease Control and Prevention
Email Address:: irn3@cdc.gov